Skip to main content
. Author manuscript; available in PMC: 2021 Mar 8.
Published in final edited form as: Clin Pharmacol Ther. 2019 Dec 5;107(3):553–562. doi: 10.1002/cpt.1634

Table 2.

Parameter estimates of final model and stability assessment using non-parametric bootstrap analysis

Parameters Base Model Final Model Non-parametric bootstrap
Estimate (%RSE) Estimate (%RSE) Mean(95% CI)
MDS-UPDRS23 Baseline 30.3 (1.54%) 29.5 (2.30%) 29.5 (28.3, 30.8)
 Age (Centered at 63 years old) NE 0.376 (22.20%) 0.378 (0.199,0.563)
 Female NE −0.0968 (27.70%) −0.0964 (−0.148, −0.042)
 Cohort (ICICLE-PD, PPMI Genetic Cohort PD, PPMI Genetic Registry PD) NE 0.134 (25.30%) 0.133 (0.0689,0.203)
 Any PD medications NE 0.112 (40.40%) 0.111 (0.0217, 0.214)
Intrinsic Progression Rate (per month) 0.00974 (8.39%) 0.0101 (8.91%) 0.0102 (0.0085, 0.012)
 LRRK2 mutation NE −0.235 (37.40%) −0.250 (−0.513, −0.0269)
Dispersion factor of Beta Distribution 37.3 (2.53%) 39.2 (2.57%) 39.3 (35, 43.8)
Random Effect
 MDS-UPDRS23 Baseline 0.162 (5.87%) 0.15 (6.26%) 0.149 (0.13, 0.168)
 Intrinsic Progression Rate 2.67 (19.7%) 0.000236 (9.66%) 0.000237 (0.000185, 0.000298)
 Correlation between Baseline and Intrinsic Progression Rate 0.111 (40.6%) 0.001270 (28.8%) 0.001270 (0.000523, 0.00216)

Abbreviations: ICICLE = Incidence of Cognitive Impairment in Cohorts with Longitudinal Evaluation, LRRK2 = Leucine-rich repeat kinase 2, MDS-UPDRS23 = Movement Disorder Society-Unified Parkinson's Disease Rating Scale part 2 plus part 3 score, NE = not evaluated, PD = Parkinson’s Disease, PPMI = Parkinson’s Progression Marker Initiative, RSE = relative standard error

Notes: 95% CI = 95% confidence interval of parameter estimate based on bootstrap results. Baseline and the typical progression rate in MDS-UPDRS23 score can be estimated as follows: MDS-UPDRS23 Baseline = 29.5*[(1 + 0.134) if Other Cohort-PD]*[(1–0.0968) if Female]]*[(1+0.112) if Any PD medication]* ((AGE/63)0.376). Intrinsic Progression Rate = 0.0101*[(1–0.235) if LRRK2 mutation]. The typical progression rate in MDS-UPDRS23 score was estimated to be dScore/dt=r*Score*(1-Score/max(Score)) = 29.5*0.0101*(1-[29.5/118]), which was approximately 0.22 point/per months.